Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Buy
62
MLAB Quote, Financials, Valuation and Earnings
Last price:
$89.93
Seasonality move
:
8.14%
Day range:
$88.38 - $92.15
52-week range:
$55.45 - $152.03
Dividend yield:
0.71%
P/E ratio:
140.32x
P/S ratio:
2.02x
P/B ratio:
2.68x
Volume:
37.6K
Avg. volume:
92.1K
1-year change:
-37.79%
Market cap:
$500.5M
Revenue:
$241M
EPS (TTM):
$0.65
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
$63.2M | $1.47 | 4.93% | 148.96% | $104.50 |
|
CGNX
Cognex Corp.
|
$238.9M | $0.22 | 11.21% | 52.37% | $53.90 |
|
DPLS
DarkPulse, Inc.
|
-- | -- | -- | -- | -- |
|
SMIT
Schmitt Industries, Inc.
|
-- | -- | -- | -- | -- |
|
SOTK
Sono-Tek Corp.
|
$5.3M | $0.02 | 9.37% | -3.85% | $6.38 |
|
WELX
Winland Holdings Corp.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
$90.59 | $104.50 | $500.5M | 140.32x | $0.16 | 0.71% | 2.02x |
|
CGNX
Cognex Corp.
|
$58.79 | $53.90 | $9.7B | 86.90x | $0.09 | 0.55% | 10.01x |
|
DPLS
DarkPulse, Inc.
|
$0.0002 | -- | $3.1M | 4.69x | $0.00 | 0% | 7.43x |
|
SMIT
Schmitt Industries, Inc.
|
$0.0177 | -- | $68.5K | -- | $0.00 | 0% | 0.01x |
|
SOTK
Sono-Tek Corp.
|
$4.10 | $6.38 | $64.4M | 40.96x | $0.00 | 0% | 3.16x |
|
WELX
Winland Holdings Corp.
|
$2.50 | -- | $12.4M | 3.17x | $0.00 | 0% | 2.32x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
47.66% | -0.105 | 39.2% | 1.32x |
|
CGNX
Cognex Corp.
|
4.88% | 2.252 | 1.27% | 2.73x |
|
DPLS
DarkPulse, Inc.
|
-11.54% | -2.491 | 35.92% | 0.05x |
|
SMIT
Schmitt Industries, Inc.
|
-- | -1.862 | -- | -- |
|
SOTK
Sono-Tek Corp.
|
-- | 0.331 | -- | 3.41x |
|
WELX
Winland Holdings Corp.
|
0.06% | 1.331 | 0.03% | 4.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
$37.6M | $8M | 1.04% | 2.19% | 12.25% | $18M |
|
CGNX
Cognex Corp.
|
$165.9M | $35.3M | 7.31% | 7.68% | 13.98% | $72.3M |
|
DPLS
DarkPulse, Inc.
|
-$214.1K | -$563.9K | -- | -- | -1107.86% | $415.7K |
|
SMIT
Schmitt Industries, Inc.
|
-- | -- | -- | -- | -- | -- |
|
SOTK
Sono-Tek Corp.
|
$2.4M | $319K | 8.63% | 8.63% | 6.37% | $1.1M |
|
WELX
Winland Holdings Corp.
|
$334K | -$13K | 47.93% | 47.99% | -1.01% | $282K |
Mesa Laboratories, Inc. vs. Competitors
-
Which has Higher Returns MLAB or CGNX?
Cognex Corp. has a net margin of 5.57% compared to Mesa Laboratories, Inc.'s net margin of 12.95%. Mesa Laboratories, Inc.'s return on equity of 2.19% beat Cognex Corp.'s return on equity of 7.68%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.57.66% $0.65 $356.7M CGNXCognex Corp.65.75% $0.19 $1.6B -
What do Analysts Say About MLAB or CGNX?
Mesa Laboratories, Inc. has a consensus price target of $104.50, signalling upside risk potential of 15.36%. On the other hand Cognex Corp. has an analysts' consensus of $53.90 which suggests that it could fall by -8.32%. Given that Mesa Laboratories, Inc. has higher upside potential than Cognex Corp., analysts believe Mesa Laboratories, Inc. is more attractive than Cognex Corp..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 CGNXCognex Corp.10 6 0 -
Is MLAB or CGNX More Risky?
Mesa Laboratories, Inc. has a beta of 0.891, which suggesting that the stock is 10.935% less volatile than S&P 500. In comparison Cognex Corp. has a beta of 1.533, suggesting its more volatile than the S&P 500 by 53.304%.
-
Which is a Better Dividend Stock MLAB or CGNX?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.71%. Cognex Corp. offers a yield of 0.55% to investors and pays a quarterly dividend of $0.09 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Cognex Corp. pays out 48.1% of its earnings as a dividend. Cognex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Mesa Laboratories, Inc.'s is not.
-
Which has Better Financial Ratios MLAB or CGNX?
Mesa Laboratories, Inc. quarterly revenues are $65.1M, which are smaller than Cognex Corp. quarterly revenues of $252.3M. Mesa Laboratories, Inc.'s net income of $3.6M is lower than Cognex Corp.'s net income of $32.7M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is 140.32x while Cognex Corp.'s PE ratio is 86.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 2.02x versus 10.01x for Cognex Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.2.02x 140.32x $65.1M $3.6M CGNXCognex Corp.10.01x 86.90x $252.3M $32.7M
-
Which has Higher Returns MLAB or DPLS?
DarkPulse, Inc. has a net margin of 5.57% compared to Mesa Laboratories, Inc.'s net margin of -1499.21%. Mesa Laboratories, Inc.'s return on equity of 2.19% beat DarkPulse, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.57.66% $0.65 $356.7M DPLSDarkPulse, Inc.-420.63% -- -$16.2M -
What do Analysts Say About MLAB or DPLS?
Mesa Laboratories, Inc. has a consensus price target of $104.50, signalling upside risk potential of 15.36%. On the other hand DarkPulse, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Mesa Laboratories, Inc. has higher upside potential than DarkPulse, Inc., analysts believe Mesa Laboratories, Inc. is more attractive than DarkPulse, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 DPLSDarkPulse, Inc.0 0 0 -
Is MLAB or DPLS More Risky?
Mesa Laboratories, Inc. has a beta of 0.891, which suggesting that the stock is 10.935% less volatile than S&P 500. In comparison DarkPulse, Inc. has a beta of -1.451, suggesting its less volatile than the S&P 500 by 245.128%.
-
Which is a Better Dividend Stock MLAB or DPLS?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.71%. DarkPulse, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. DarkPulse, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or DPLS?
Mesa Laboratories, Inc. quarterly revenues are $65.1M, which are larger than DarkPulse, Inc. quarterly revenues of $50.9K. Mesa Laboratories, Inc.'s net income of $3.6M is higher than DarkPulse, Inc.'s net income of -$763.1K. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is 140.32x while DarkPulse, Inc.'s PE ratio is 4.69x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 2.02x versus 7.43x for DarkPulse, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.2.02x 140.32x $65.1M $3.6M DPLSDarkPulse, Inc.7.43x 4.69x $50.9K -$763.1K
-
Which has Higher Returns MLAB or SMIT?
Schmitt Industries, Inc. has a net margin of 5.57% compared to Mesa Laboratories, Inc.'s net margin of --. Mesa Laboratories, Inc.'s return on equity of 2.19% beat Schmitt Industries, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.57.66% $0.65 $356.7M SMITSchmitt Industries, Inc.-- -- -- -
What do Analysts Say About MLAB or SMIT?
Mesa Laboratories, Inc. has a consensus price target of $104.50, signalling upside risk potential of 15.36%. On the other hand Schmitt Industries, Inc. has an analysts' consensus of -- which suggests that it could grow by 67696.61%. Given that Schmitt Industries, Inc. has higher upside potential than Mesa Laboratories, Inc., analysts believe Schmitt Industries, Inc. is more attractive than Mesa Laboratories, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 SMITSchmitt Industries, Inc.0 0 0 -
Is MLAB or SMIT More Risky?
Mesa Laboratories, Inc. has a beta of 0.891, which suggesting that the stock is 10.935% less volatile than S&P 500. In comparison Schmitt Industries, Inc. has a beta of -0.606, suggesting its less volatile than the S&P 500 by 160.563%.
-
Which is a Better Dividend Stock MLAB or SMIT?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.71%. Schmitt Industries, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Schmitt Industries, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or SMIT?
Mesa Laboratories, Inc. quarterly revenues are $65.1M, which are larger than Schmitt Industries, Inc. quarterly revenues of --. Mesa Laboratories, Inc.'s net income of $3.6M is higher than Schmitt Industries, Inc.'s net income of --. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is 140.32x while Schmitt Industries, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 2.02x versus 0.01x for Schmitt Industries, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.2.02x 140.32x $65.1M $3.6M SMITSchmitt Industries, Inc.0.01x -- -- --
-
Which has Higher Returns MLAB or SOTK?
Sono-Tek Corp. has a net margin of 5.57% compared to Mesa Laboratories, Inc.'s net margin of 6.79%. Mesa Laboratories, Inc.'s return on equity of 2.19% beat Sono-Tek Corp.'s return on equity of 8.63%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.57.66% $0.65 $356.7M SOTKSono-Tek Corp.47.34% $0.02 $19.1M -
What do Analysts Say About MLAB or SOTK?
Mesa Laboratories, Inc. has a consensus price target of $104.50, signalling upside risk potential of 15.36%. On the other hand Sono-Tek Corp. has an analysts' consensus of $6.38 which suggests that it could grow by 55.49%. Given that Sono-Tek Corp. has higher upside potential than Mesa Laboratories, Inc., analysts believe Sono-Tek Corp. is more attractive than Mesa Laboratories, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 SOTKSono-Tek Corp.1 1 0 -
Is MLAB or SOTK More Risky?
Mesa Laboratories, Inc. has a beta of 0.891, which suggesting that the stock is 10.935% less volatile than S&P 500. In comparison Sono-Tek Corp. has a beta of -0.316, suggesting its less volatile than the S&P 500 by 131.564%.
-
Which is a Better Dividend Stock MLAB or SOTK?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.71%. Sono-Tek Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Sono-Tek Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or SOTK?
Mesa Laboratories, Inc. quarterly revenues are $65.1M, which are larger than Sono-Tek Corp. quarterly revenues of $5M. Mesa Laboratories, Inc.'s net income of $3.6M is higher than Sono-Tek Corp.'s net income of $340K. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is 140.32x while Sono-Tek Corp.'s PE ratio is 40.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 2.02x versus 3.16x for Sono-Tek Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.2.02x 140.32x $65.1M $3.6M SOTKSono-Tek Corp.3.16x 40.96x $5M $340K
-
Which has Higher Returns MLAB or WELX?
Winland Holdings Corp. has a net margin of 5.57% compared to Mesa Laboratories, Inc.'s net margin of --. Mesa Laboratories, Inc.'s return on equity of 2.19% beat Winland Holdings Corp.'s return on equity of 47.99%.
Company Gross Margin Earnings Per Share Invested Capital MLABMesa Laboratories, Inc.57.66% $0.65 $356.7M WELXWinland Holdings Corp.25.85% $0.37 $13.9M -
What do Analysts Say About MLAB or WELX?
Mesa Laboratories, Inc. has a consensus price target of $104.50, signalling upside risk potential of 15.36%. On the other hand Winland Holdings Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Mesa Laboratories, Inc. has higher upside potential than Winland Holdings Corp., analysts believe Mesa Laboratories, Inc. is more attractive than Winland Holdings Corp..
Company Buy Ratings Hold Ratings Sell Ratings MLABMesa Laboratories, Inc.1 2 0 WELXWinland Holdings Corp.0 0 0 -
Is MLAB or WELX More Risky?
Mesa Laboratories, Inc. has a beta of 0.891, which suggesting that the stock is 10.935% less volatile than S&P 500. In comparison Winland Holdings Corp. has a beta of 1.516, suggesting its more volatile than the S&P 500 by 51.569%.
-
Which is a Better Dividend Stock MLAB or WELX?
Mesa Laboratories, Inc. has a quarterly dividend of $0.16 per share corresponding to a yield of 0.71%. Winland Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mesa Laboratories, Inc. pays 175.68% of its earnings as a dividend. Winland Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MLAB or WELX?
Mesa Laboratories, Inc. quarterly revenues are $65.1M, which are larger than Winland Holdings Corp. quarterly revenues of $1.3M. Mesa Laboratories, Inc.'s net income of $3.6M is higher than Winland Holdings Corp.'s net income of $1.8M. Notably, Mesa Laboratories, Inc.'s price-to-earnings ratio is 140.32x while Winland Holdings Corp.'s PE ratio is 3.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mesa Laboratories, Inc. is 2.02x versus 2.32x for Winland Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MLABMesa Laboratories, Inc.2.02x 140.32x $65.1M $3.6M WELXWinland Holdings Corp.2.32x 3.17x $1.3M $1.8M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Is Sandisk The Next Big Memory Stock?
Computer memory manufacturer Sandisk (NASDAQ:SNDK) has quietly been one of…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
